Pharmacokinetics and pharmacodynamics of oral contraceptive steroids: Factors influencing steroid metabolism
- 1 December 1990
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 163 (6) , 2183-2197
- https://doi.org/10.1016/0002-9378(90)90560-t
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Binding of oral contraceptive progestogens to serum proteins and cytoplasmic receptorAmerican Journal of Obstetrics and Gynecology, 1990
- Interaction with the pharmacokinetics of ethinylestradiol and progestogens contained in oral contraceptivesContraception, 1989
- Alterations in the serum levels of gestodene and SHBG during 12 cycles of treatment with 30 μg ethinylestradiol and 75 μg gestodeneContraception, 1988
- Serum levels of 3-keto-desogestrel and SHBG during 12 cycles of treatment with 30 μg ethinylestradiol and 150 μg desogestrelContraception, 1988
- Comparative pharmacokinetics of levonqrgestrel and ethinyloestradiol following intravenous, oral and vaginal administrationContraception, 1987
- Blood levels of ethynylestradiol, caffeine, aldosterone and desoxycorticosterone in hypertensive oral contraceptive usersContraception, 1981
- Interindividual Variation and Drug Interactions with Hormonal Steroid ContraceptivesDrugs, 1981
- Variation of Ethinylestradiol Blood Levels Among Healthy Women Using Oral ContraceptivesFertility and Sterility, 1980
- Plasma Xa inhibitory activities and plasma concentrations of norgestrel and ethinyloestradiol in women on oral contraceptive steroids.Published by Wiley ,1979
- Evidence of Higher Ethynylestradiol Blood Levels in Human Hypertensive Oral Contraceptive UsersFertility and Sterility, 1977